Format

Send to

Choose Destination
FEBS Lett. 2010 Jun 18;584(12):2662-9. doi: 10.1016/j.febslet.2010.04.002. Epub 2010 Apr 11.

The molecular signature of oncofusion proteins in acute myeloid leukemia.

Author information

1
Radboud University, Department of Molecular Biology, Faculty of Science, Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands.

Abstract

Acute myeloid leukemia (AML) associated translocations often cause gene fusions that encode oncofusion proteins. Although many of the breakpoints involved in chromosomal translocations have been cloned, in most cases the role of the chimeric proteins in tumorigenesis is not elucidated. Here we will discuss the fusion proteins of the 4 most common translocations associated with AML as well as the common molecular mechanisms that these four and other fusion proteins utilize to transform progenitor cells. Intriguingly, although the individual partners within the fusion proteins represent a wide variety of cellular functions, at the molecular level many commodities can be found.

PMID:
20388510
DOI:
10.1016/j.febslet.2010.04.002
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center